Overview
The goal of this prospective randomized controlled study is to study the safety and efficacy of intralesional acyclovir compared to cryotherapy in plantar warts. The main questions needed to be answered are:
- Is Intralesional acyclovir safe for plantar warts?
- Is Intralesional acyclovir more efficient in treating plantar warts compared to cryotherapy?
Eligibility
Inclusion Criteria:
- Patients aged 18 years or older, of both genders, with plantar warts
Exclusion Criteria:
- Patients on systemic treatment for warts eg. Acitretin, Acyclovir
- Hypersensitivity to Acyclovir
- Previous treatment to the same wart during the last 3 months
- Immunocompromised patients (as HIV, steroid intake, uncontrolled diabetes, etc.)
- Pregnant and breastfeeding females
- Cognitively impaired patients